首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1366篇
  免费   65篇
各国政治   103篇
工人农民   76篇
世界政治   111篇
外交国际关系   108篇
法律   687篇
中国共产党   1篇
中国政治   19篇
政治理论   323篇
综合类   3篇
  2023年   12篇
  2022年   16篇
  2021年   42篇
  2020年   47篇
  2019年   64篇
  2018年   63篇
  2017年   74篇
  2016年   67篇
  2015年   45篇
  2014年   66篇
  2013年   224篇
  2012年   60篇
  2011年   81篇
  2010年   28篇
  2009年   41篇
  2008年   45篇
  2007年   63篇
  2006年   43篇
  2005年   21篇
  2004年   38篇
  2003年   27篇
  2002年   27篇
  2001年   25篇
  2000年   28篇
  1999年   14篇
  1998年   12篇
  1997年   13篇
  1996年   16篇
  1995年   14篇
  1994年   10篇
  1993年   11篇
  1992年   13篇
  1991年   10篇
  1990年   8篇
  1989年   8篇
  1988年   7篇
  1987年   5篇
  1986年   2篇
  1985年   2篇
  1984年   9篇
  1982年   3篇
  1981年   2篇
  1979年   2篇
  1978年   3篇
  1977年   4篇
  1969年   3篇
  1967年   1篇
  1966年   1篇
  1965年   1篇
  1963年   1篇
排序方式: 共有1431条查询结果,搜索用时 15 毫秒
991.
992.
993.
994.
995.
Any system for the protection of intellectual property rights (IPRs) has three main kinds of distributive effects. It will determine or influence: (a) the types of objects that will be developed and for which IPRs will be sought; (b) the differential access various people will have to these objects; and (c) the distribution of the IPRs themselves among various actors. What this means to the area of pharmaceutical research is that many urgently needed medicines will not be developed at all, that the existing medicines will not be suitable for countries with a precarious health infrastructure or not target the disease variety that is prevalent in poorer regions. Such effects are commonly captured under the rubric of the “10/90 gap” in biomedical research. High prices will also restrict access to medicines as well endanger compliance to treatment schemes. IPRs are mainly held by multinational corporations situated in the developed world, which not only raises egalitarian concerns, but also severely limits the possibilities of companies in poorer countries to realize improvements on existing inventions, as they cannot financially afford to secure freedom to operate, which systematically shrinks the number of potential innovators. Those inequities lead to an enormous burden for the global poor and since no institution is willing to assume the responsibility to fulfil the right to health and the corresponding right of access to essential medicines, we have to analyse alternatives or additions to the actual intellectual property regimes in order to create new incentives to fill this gap.  相似文献   
996.
Family First     
My decision to come to China was a pretty simple one:curiosity.I am originally from Holland,but have always been fascinated with China-this mysterious and rising oriental superpower.I bought books and movies on the country,wishing to satisfy my questions.On the contrary,it only inspired more.With China’s economy booming,many amazing career opportunities are currently open to foreigners like me.It was a very natural decision for me to come to explore the possibilities in China.Beijing brims with opportunities and ancient Chinese culture,which is the reason I have made it my home.  相似文献   
997.
998.
The aim of this paper is to empirically examine the influence of credibility on the likelihood to grant consortia of collaborating actors an innovation subsidy. Theorizing from the viewpoint of resource dependence theory and the sociology of expectations, we hypothesize that four types of credibility of influence: scientific credibility, market credibility, expectation track record, and generated social capital. We operate on two levels of analysis, the actor and the consortium. We quantitatively analyze the Dutch electric vehicle subsidy program as case. We develop a model that accurately forecasts which consortia are most likely to receive subsidies. We demonstrate that generated social capital and market credibility positively influence the likelihood of receiving innovation subsidies, while scientific credibility sources and expectation track record have a negative influence. Based on these findings we provide policy recommendations and avenues for further research.  相似文献   
999.
1000.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号